Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues.
The company reported worldwide net revenues of $12.31 billion for the March quarter, up 1% from the corresponding period of 2023.
Net income, adjusted for special items, declined to $2.31 per share in Q1 from $2.46 per share in the year-ago quarter. On a reported basis, first-quarter profit was $1.37 billion or $0.77 per share, compared to $239 million $0.13 per share last year.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Micron Q1 2026 earnings beat estimates; revenue surges 57%
Memory chipmaker Micron Technology Inc. (NASDAQ: MU) on Wednesday reported stronger-than-expected earnings for the first quarter of fiscal 2026. Revenue increased 57% year-over-year. First-quarter revenues rose sharply to $13.6 billion
Carnival Corporation to report Q4 earnings on Dec. 19. Here’s what to expect
When Carnival Corporation (NYSE: CCL) reports its fourth-quarter results on Friday, investors will be closely watching demand trends, pricing, and cost discipline, following a year marked by operational recovery. The
General Mills (GIS) aims to generate double-digit sales growth from new products in FY2026
Shares of General Mills, Inc. (NYSE: GIS) gained over 2% on Wednesday after the company posted better-than-expected earnings results for the second quarter of 2026. Revenue and earnings declined versus
